NCT03572972View on ClinicalTrials.gov

Non-interventional, Retrospective Cohort Study to Explore OAC Treatment in Korea

CompletedOBSERVATIONAL
Enrollment

64,684

Participants

Timeline

Start Date

January 31, 2018

Primary Completion Date

December 20, 2018

Study Completion Date

December 20, 2018

Conditions
Atrial Fibrillation
Interventions
DRUG

Apixaban

Treatment for NVAF patients

DRUG

Dabigatran

Treatment for NVAF patients

DRUG

Rivaroxaban

Treatment for NVAF patients

DRUG

warfarin

Treatment for NVAF patients

DRUG

Antiplatelets

Treatment for NVAF patients

Trial Locations (1)

Unknown

Korea University Hospital, Seoul

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03572972 - Non-interventional, Retrospective Cohort Study to Explore OAC Treatment in Korea | Biotech Hunter | Biotech Hunter